Clinical Trial Update: Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating regadenoson-stressed cardiovascular magnetic resonance for detecting coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Regadenoson (Regadenoson)

Snippet

Sponsor: Dipan Shah | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN